Oxidative stress and inflammation in the development of cardiovascular disease and contrast induced nephropathy

Abstract

Utilization of contrast media to visualize vasculature structures in the setting of cardiovascular disorders (CVD) can lead to acute kidney injury, referred to as contrast-induced nephropathy (CIN). CIN can potentiate mortality and hospitalization in aged individuals, patients with CVD, nephropathy, enhancing kidney damage, and cardiac events. Preventing CIN by identifying risk factors is important. The underlying mechanisms of CIN pathology are unclear, but the key factors include direct cytotoxicity, oxidative stress, vascular and endothelial dysfunction and inflammatory processes. Reactive Oxygen Species and inflammatory mediators have been proposed as key factors influencing the development of CIN and CVD, and the elucidation of the interplay between the mechanisms evoked by them may provide a better understanding of the signaling processes happening in these conditions, thereby potentially enabling early identification, prevention and characterization of novel drug targets.

Keywords

Contrast induced nephropathy / cardiovascular disorders / oxidative stress / inflammation / reactive oxygen species

References

[1] Chen L,Cui H,Zuo Z.Inflammatory responses and inflammation-associated diseases in organs..Oncotarget2018;9:7204-18 PMCID:PMC5805548

[2] Mittal M,Tran K,Malik AB.Reactive oxygen species in inflammation and tissue injury..Antioxidants Redox Signal2014;20:1126-67 PMCID:PMC3929010

[3] Kim YM,Tatsunami R,Fukai T.ROS-induced ROS release orchestrated by Nox4, Nox2, and mitochondria in VEGF signaling and angiogenesis..Am J Physiol - Cell Physiol2017;312:C749-64 PMCID:PMC5494593

[4] Chelombitko MA.Role of reactive oxygen species in inflammation: a minireview..Moscow Univ Biol Sci Bull2018;73:199-202

[5] Yang W,Wu Y,Ye W.Neutrophils promote the development of reparative macrophages mediated by ROS to orchestrate liver repair..Nat Commun2019;10:1076 PMCID:PMC6403250

[6] Dröge W.Free radicals in the physiological control of cell function..Physiol Rev2002;82:47-95

[7] Cai Z.Protein oxidative modifications: beneficial roles in disease and health..J Biochem Pharmacol Res2013;1:15-26 PMCID:PMC3646577

[8] Cobley JN.Immunological techniques to assess protein thiol redox state: opportunities, challenges and solutions..Antioxidants2020;9:31 PMCID:PMC7222201

[9] Ranneh Y,Akim AM,Khazaai H.Crosstalk between reactive oxygen species and pro-inflammatory markers in developing various chronic diseases: a review..Appl Biol Chem2017;60:327-38

[10] Reuter S,Chaturvedi MM.Oxidative stress, inflammation, and cancer: how are they linked?.Free Radic Biol Med2010;49:1603-16 PMCID:PMC2990475

[11] Austin V,Bozinovski S,Vlahos R.COPD and stroke: are systemic inflammation and oxidative stress the missing links?.Clin Sci2016;130:1039-50 PMCID:PMC4876483

[12] Rovira-Llopis S,Falcon R,Alvarez A.Is myeloperoxidase a key component in the ROS-induced vascular damage related to Nephropathy in type 2 diabetes?.Antioxidants Redox Signal2013;19:1452-8 PMCID:PMC3797450

[13] Hansen PR.Chronic inflammatory diseases and atherosclerotic cardiovascular disease: innocent bystanders or partners in crime?.Curr Pharm Des2018;24:281-90

[14] Lorenzatti AJ.New evidence on the role of inflammation in CVD risk..Curr Opin Cardiol2019;34:418-23

[15] Cervantes Gracia K,Husi H.CVD and oxidative stress..J Clin Med2017;6:22 PMCID:PMC5332926

[16] Williams B,Spiering W,Azizi M.2018 ESC/ESH Guidelines for themanagement of arterial hypertension..Eur Heart J2018;39:3021-104

[17] Vasan RS,Niiranen TJ,DeCarli C.Interrelations between arterial stiffness, target organ damage, and cardiovascular disease outcomes..J Am Heart Assoc2019;8:e012141 PMCID:PMC6662123

[18] Briasoulis A.Chronic kidney disease as a coronary artery disease risk equivalent..Curr Cardiol Rep2013;15:340

[19] Yuan J,Han SP,Wang L.Prevalence and risk factors for cardiovascular disease among chronic kidney disease patients: results from the Chinese cohort study of chronic kidney disease (C-STRIDE)..BMC Nephrol2017;18:23 PMCID:PMC5237491

[20] Tomey MI.Cardiovascular pathophysiology in chronic kidney disease: opportunities to transition from disease to health..Ann Glob Health2014;80:69-76

[21] Subbiah AK,Mahajan S.Cardiovascular disease in patients with chronic kidney disease: a neglected subgroup..Heart Asia2016;8:56-61 PMCID:PMC5133395

[22] Rahman M,Feldman HI,He J.Association between chronic kidney disease progression and cardiovascular disease: results from the CRIC study..Am J Nephrol2014;40:399-407 PMCID:PMC4275411

[23] Gleeson TG.Contrast-induced nephropathy..Am J Roentgenol2004;183:1673-89

[24] Pyxaras SA,Mangiacapra F,Di Serafino L.Contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention without acute left ventricular ejection fraction impairment..Am J Cardiol2013;111:684-8

[25] Sato A,Watanabe M,Tamaki N.Association of contrast-induced nephropathy with risk of adverse clinical outcomes in patients with cardiac catheterization: from the CINC-J study..Int J Cardiol2017;227:424-9

[26] Rear R,Hausenloy DJ.Contrast-induced nephropathy following angiography and cardiac interventions..Heart2016;102:638-48 PMCID:PMC4819627

[27] Hossain MA,Cosentino J,Qaisar H.Contrast-induced nephropathy: pathophysiology, risk factors, and prevention..Saudi J Kidney Dis Transpl2018;29:1-9

[28] McDonald JS,Tran CL,Williamson EE.Postcontrast acute kidney injury in pediatric patients: a cohort study..Am J Kidney Dis2018;72:811-8

[29] Demirtas L,Kandemir FM,Kucukler S.The possible role of interleukin-33 as a new player in the pathogenesis of contrast-induced nephropathy in diabetic rats..Ren Fail2016;38:952-60

[30] Oweis AO,Daoud AK,Alzoubi KH.Inflammatory milieu in contrast-induced nephropathy: a prospective single-center study..Int J Nephrol Renovasc Dis2018;11:211-5 PMCID:PMC6095120

[31] Yildirim E,Cengiz M.Inflammatory markers of contrast-induced nephropathy in patients with acute coronary syndrome..Coron Artery Dis2020;31:279-83

[32] Murashima M,Kokubu M,Matsui M.Inflammation as a predictor of acute kidney injury and mediator of higher mortality after acute kidney injury in non-cardiac surgery..Sci Rep2019;9:20260 PMCID:PMC6937243

[33] de Souza Santos V,Côco LZ,de Assis ALEM.Silymarin protects against radiocontrast-induced nephropathy in mice..Life Sci2019;228:305-15

[34] Kim JE,Ahn SY,Ko GJ.The role of nuclear factor erythroid-2-related factor 2 expression in radiocontrast-induced nephropathy..Sci Rep2019;9:2608 PMCID:PMC6384919

[35] Kaptoge S,De Bacquer D,Kavousi M.World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions..Lancet Glob Health2019;7:e1332-45 PMCID:PMC7025029

[36] Roth GA,Abate KH,Abbafati C.Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017..Lancet2018;392:1736-88 PMCID:PMC6227606

[37] Astin F,Thompson DR.Prevalence and patterns of anxiety and depression in patients undergoing elective percutaneous transluminal coronary angioplasty..Heart Lung2005;34:393-401

[38] Chhabra L,Siddiqui WJ.Angioplasty. In: StatPearls.2020;Treasure Island (FL)StatPearls Publishing

[39] Nadolski GJ.Contrast alternatives for iodinated contrast allergy and renal dysfunction: options and limitations..J Vasc Surg2013;57:593-8

[40] Schraeder R.Contrast media selection in interventional cardiology..J Clin Basic Cardiol2001;4:245-8

[41] Al Shammeri O.Thrombolysis in the age of primary percutaneous coronary intervention: mini-review and meta-analysis of early PCI..Int J Health Sci (Qassim)2013;7:91-100 PMCID:PMC3612420

[42] Barauskas M,Tamulenaite E.The impact of clinical and angiographic factors on percutaneous coronary angioplasty outcomes in patients with acute ST-elevation myocardial infarction..Arch Med Sci Atheroscler Dis2016;1:e150-7 PMCID:PMC5421528

[43] Darvishpour A,Salari A,Taleshan-Nejad M.Factors associated with quality of life in patients undergoing coronary angioplasty..Int J Health Sci (Qassim)2017;11:35-41 PMCID:PMC5654185

[44] Kim MJ,Gwon HC,Chang K.Health-related quality-of-life after percutaneous coronary intervention in patients with UA/NSTEMI and STEMI: the Korean multicenter registry..J Korean Med Sci2013;28:848-54 PMCID:PMC3678000

[45] Mandal A,Kafle P,Bhattarai B.Contrast-induced nephropathy following percutaneous coronary intervention at a tertiary cardiac center in Nepal..Cureus2018;10:e3331 PMCID:PMC6248688

[46] Windecker S,Alfonso F,Cremer J.2014 ESC/EACTS Guidelines on Myocardial Revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed With the Special Contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)..Eur Heart J2014;35:2541-619

[47] Manske CL,Strony JT.Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography..Am J Med1990;89:615-20

[48] Diamantopoulos A,Santonocito S,Ilyas S.Carbon dioxide angiography during peripheral angioplasty procedures significantly reduces the risk of contrast-induced nephropathy in patients with chronic kidney disease..CVIR Endovasc2020;3:9 PMCID:PMC7024684

[49] Ghumman SS,Khan A,Levin D.Contrast-induced nephropathy following peripheral angiography with carbon dioxide versus iodinated contrast media: a systematic review and meta-analysis of current literature..J Am Coll Cardiol2017;69:2088

[50] Andreis A,Levis M,Usmiani T.Contrast-induced kidney injury: how does it affect long-term cardiac mortality?.J Cardiovasc Med2017;18:908-15

[51] Neyra JA,Mooney R,Yee J.Contrast-induced acute kidney injury following coronary angiography: a cohort study of hospitalized patients with or without chronic kidney disease..Nephrol Dial Transplant2013;28:1463-71

[52] Schilp J,Langelaan M,Wagner C.Guideline adherence for identification and hydration of high-risk hospital patients for contrast-induced nephropathy..BMC Nephrol2014;15:2 PMCID:PMC3890484

[53] Haq MFU,Arora P.The conundrum of contrast-induced acute kidney injury..J Thorac Dis2020;12:1721-7 PMCID:PMC7212164

[54] Marenzi G,Assanelli E,De Metrio M.Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction..J Am Coll Cardiol2004;44:1780-5

[55] Mehran R,Nikolsky E,Iakovou I.A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: Development and initial validation..J Am Coll Cardiol2004;44:1393-9

[56] Tsai TT,Chang TI,Masoudi FA.Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR cath-PCI registry..JACC Cardiovasc Interv2014;7:1-9 PMCID:PMC4122507

[57] Watabe H,Hoshi T,Abe D.Association of contrast-induced acute kidney injury with long-term cardiovascular events in acute coronary syndrome patients with chronic kidney disease undergoing emergent percutaneous coronary intervention..Int J Cardiol2014;174:57-63

[58] Berwanger O.Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: Main results from the randomized acetylcysteine for contrast-induced nephropathy trial (ACT)..Circulation2011;124:1250-9

[59] Bolognese L,Schwenke C,Limbruno U.Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention..Am J Cardiol2012;109:67-74

[60] Mohammed NA,Mahfouz A,Hajar R.Contrast-induced nephropathy..Heart Views2013;14:106-16 PMCID:PMC3969626

[61] McCullough PA.Contrast-induced nephropathy..Crit Care Clin2005;21:261-80

[62] Mamoulakis C,Fragkiadoulaki I,Wilks MF.Contrast-induced nephropathy: basic concepts, pathophysiological implications and prevention strategies..Pharmacol Ther2017;180:99-112

[63] Solomon R.Contrast-induced acute kidney injury..Circulation2010;122:2451-5

[64] Morcos R,Bansal P,Manam R.Contrast-induced acute kidney injury: review and practical update..Clin Med Insights Cardiol2019;13:1179546819878680 PMCID:PMC6826945

[65] Ward DB.Contrast induced acute kidney injury and direct cytotoxicity of iodinated radiocontrast media on renal proximal tubule cells..J Pharmacol Exp Ther2019;370:160-71

[66] Celik T,Balta S,Unal HU.The relationship between plasma whole blood viscosity and cardiovascular events in patients with chronic kidney disease..Clin Appl Thromb2017;23:663-70

[67] Peters SAE,Rumley A,Lowe GDO.Plasma and blood viscosity in the prediction of cardiovascular disease and mortality in the Scottish Heart Health Extended Cohort Study..Eur J Prev Cardiol2017;24:161-7

[68] Sugimori H,Koike T,Masutani T.Increased blood viscosity is associated with reduced renal function and elevated urinary albumin excretion in essential hypertensives without chronic kidney disease..Hypertens Res2013;36:247-51

[69] Ferrario CM.Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease..Pharmacol Res2017;125:57-71 PMCID:PMC5648016

[70] Gavras I.Angiotensin II as a cardiovascular risk factor..J Hum Hypertens.2002;16 Suppl 2:S2-6

[71] Ibrahim NE,McCarthy C,Li Y.Endothelin-1 predicts incident heart failure, incident myocardial infarction, cardiovascular mortality, and all-cause mortality in patients undergoing diagnostic coronary angiography: results from the catheter sampled blood archive in cardiovascular disease (CASABLANCA) study..J Am Coll Cardiol2018;71:A773

[72] Ozkok S.Contrast-induced acute kidney injury: A review of practical points..World J Nephrol2017;6:86-99 PMCID:PMC5424439

[73] Reiss AB,Kasselman LJ,Vernice NA.Adenosine and the cardiovascular system..Am J Cardiovasc Drugs2019;19:449-64 PMCID:PMC6773474

[74] Huang YT,Lai YH,Lin TC.Resveratrol alleviates the cytotoxicity induced by the radiocontrast agent, ioxitalamate, by reducing the production of reactive oxygen species in HK-2 human renal proximal tubule epithelial cells in vitro..Int J Mol Med2016;37:83-91 PMCID:PMC4687441

[75] Jeong BY,Park CG,Yu SL.Oxidative stress caused by activation of NADPH oxidase 4 promotes contrast-induced acute kidney injury..PLoS One2018;13:e0191034 PMCID:PMC5766150

[76] Chen Q,Ding D,Li D.Estimated glomerular filtration rate and mortality among patients with coronary heart disease..PLoS One2016;11:e0161599 PMCID:PMC4990321

[77] Dan Dunn J,Zhang X.Reactive oxygen species and mitochondria: a nexus of cellular homeostasis..Redox Biol2015;6:472-85 PMCID:PMC4596921

[78] Murphy MP.How mitochondria produce reactive oxygen species..Biochem J2009;417:1-13 PMCID:PMC2605959

[79] Plotnikov EY,Zorova LD,Prusov AN.Mitochondrial damage and mitochondria-targeted antioxidant protection in LPS-induced acute kidney injury..Antioxidants2019;8:176 PMCID:PMC6617298

[80] Tang C,Yan M,Liu J.PINK1-PRKN/PARK2 pathway of mitophagy is activated to protect against renal ischemia-reperfusion injury..Autophagy2018;14:880-97 PMCID:PMC6070003

[81] Bhatti JS,Reddy PH.Mitochondrial dysfunction and oxidative stress in metabolic disorders - A step towards mitochondria based therapeutic strategies..Biochim Biophys Acta - Mol Basis Dis2017;1863:1066-77 PMCID:PMC5423868

[82] Nicolson GL.Mitochondrial dysfunction and chronic disease: Treatment with natural supplements..Integr Med (Encinitas)2014;13:35-43 PMCID:PMC4566449

[83] Senoner T.Oxidative stress in cardiovascular diseases: Still a therapeutic target?.Nutrients2019;11:2090 PMCID:PMC6769522

[84] Chistiakov DA,Melnichenko AA,Orekhov AN.The role of mitochondrial dysfunction in cardiovascular disease: a brief review..Ann Med2018;50:121-7

[85] Peoples JN,Ghazal N,Kwong JQ.Mitochondrial dysfunction and oxidative stress in heart disease..Exp Mol Med2019;51:1-13 PMCID:PMC6923355

[86] Siasos G,Kosmopoulos M,Simantiris S.Mitochondria and cardiovascular diseases - from pathophysiology to treatment..Ann Transl Med2018;6:256 PMCID:PMC6046286

[87] Korge P,Calmettes G.Reactive oxygen species production induced by pore opening in cardiac mitochondria: the role of complex II..J Biol Chem2017;292:9896-905 PMCID:PMC5473242

[88] Manskikh VN,Nikiforova AI,Shabalina IG.Age-associated murine cardiac lesions are attenuated by the mitochondria-targeted antioxidant SkQ1..Histol Histopathol2015;30:353-60

[89] Behringer EJ.Impact of aging on calcium signaling and membrane potential in endothelium of resistance arteries: a role for mitochondria..J Gerontol A Biol Sci Med Sci2017;72:1627-37 PMCID:PMC5861896

[90] Bigelman E,Aharon-Hananel G,Rozenbaum Z.Pathological presentation of cardiac mitochondria in a rat model for chronic kidney disease..PLoS One2018;13:e0198196 PMCID:PMC5995391

[91] Kocas C,Abaci O,Firdin N.Platelet-to-lymphocyte ratio predicts contrast-induced nephropathy in patients with non-ST-segment elevation acute coronary syndrome..Angiology2015;66:964-8

[92] Yuan Y,Hu X,Gao X.Predictive value of inflammatory factors on contrast-induced acute kidney injury in patients who underwent an emergency percutaneous coronary intervention..Clin Cardiol2017;40:719-25 PMCID:PMC6490320

[93] Zhao K,Gao Q.Role of red blood cell distribution width in predicting contrast induced nephropathy in patients with stable angina pectoris undergoing percutaneous coronary intervention..Int J Cardiol2015;197:276-8

[94] Zorlu C.Comparison of the relationship between inflammatory markers and contrast-induced nephropathy in patients with acute coronary syndrome after coronary angiography..Angiology2020;71:249-55

[95] Ronco C,House AA,Bellomo R.Cardiorenal Syndrome..J Am Coll Cardiol2008;52:1527-39

[96] Go AS,Fan D,Hsu CY.Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization..N Engl J Med2004;351:1296-305

[97] Schiffrin EL,Mann JFE.Chronic kidney disease: effects on the cardiovascular system..Circulation2007;116:85-97

[98] Tokuyama H,Zhang Y,Gilbert RE.Macrophage infiltration and cellular proliferation in the non-ischemic kidney and heart following prolonged unilateral renal ischemia..Nephron Physiol2007;106:54-62

[99] Halliwell B.Role of free radicals in the neurodegenerative diseases: Therapeutic implications for antioxidant treatment..Drugs Aging2001;18:685-716

[100] Incalza MA,Natalicchio A,Laviola L.Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases..Vascul Pharmacol2018;100:1-19

[101] Tang X,Chen HZ.Mitochondria, endothelial cell function, and vascular diseases..Front Physiol2014;5:175 PMCID:PMC4018556

[102] Cobley J,Bessell R,Husi H.Reversible thiol oxidation inhibits the mitochondrial ATP synthase in xenopus laevis oocytes..Antioxidants2020;9:215 PMCID:PMC7139892

[103] Cobley JN,Jimenez-Fernandez E,Guille M.Catalyst-free Click PEGylation reveals substantial mitochondrial ATP synthase sub-unit alpha oxidation before and after fertilisation..Redox Biol2019;26:101258 PMCID:PMC6597785

[104] Plotnikov EY.Pros and cons of use of mitochondria-targeted antioxidants..Antioxidants.2019;8:316 PMCID:PMC6719234

[105] Liguori I,Curcio F,Aran L.Oxidative stress, aging, and diseases..Clin Interv Aging2018;13:757-72 PMCID:PMC5927356

[106] Abete P,Santoro G,Tritto I.Age-related decrease in cardiac tolerance to oxidative stress..J Mol Cell Cardiol1999;31:227-36

[107] Persson PB,Liss P.Pathophysiology of contrast medium-induced nephropathy..Kidney Int2005;68:14-22

[108] Caiazza A,Sabbatini M.Hemodynamic and tubular changes induced by contrast media..Biomed Res Int2014;2014:578974 PMCID:PMC3941595

[109] Brinkley TE,Kanaya AM,Lakatta EG.Plasma oxidized low-density lipoprotein levels and arterial stiffness in older adults the health, aging, and body composition study..Hypertension2009;53:846-52 PMCID:PMC2692957

[110] Zuliani G,Volpato S,Tch CB.Determinants and clinical significance of plasma oxidized LDLs in older individuals. A 9 years follow-up study..Atherosclerosis2013;226:201-7 PMCID:PMC3529836

[111] Burtenshaw D,Redmond EM,Cahill PA.Reactive Oxygen Species (ROS), Intimal Thickening, and Subclinical Atherosclerotic Disease..Front Cardiovasc Med2019;6:89 PMCID:PMC6688526

[112] Kattoor AJ,Palagiri D.Oxidative stress in atherosclerosis..Curr Atheroscler Rep2017;19:42

[113] Rivera J,Walduck AK.Nox isoforms in vascular pathophysiology: insights from transgenic and knockout mouse models..Redox Rep2010;15:50-63 PMCID:PMC7067321

[114] Craige SM,Reif M,Pei Y.Endothelial NADPH oxidase 4 protects ApoE-/- mice from atherosclerotic lesions..Free Radic Biol Med2015;89:1-7 PMCID:PMC4783146

[115] Liu XH,Pan LL,Xu P.NADPH oxidase 4 contributes to connective tissue growth factor expression through Smad3-dependent signaling pathway..Free Radic Biol Med2016;94:174-84

[116] Gray SP,Kennedy K,Okabe J.Reactive oxygen species can provide atheroprotection via NOX4-dependent inhibition of inflammation and vascular remodeling..Arterioscler Thromb Vasc Biol2016;36:295-307

[117] Wu RF,Liu Z.Nox4-derived H₂O₂ mediates endoplasmic reticulum signaling through local ras activation..Mol Cell Biol2010;30:3553-68 PMCID:PMC2897542

[118] Martin D,Yang J,Margariti A.Unspliced X-box-binding protein 1 (XBP1) protects endothelial cells from oxidative stress through interaction with histone deacetylase 3..J Biol Chem2014;289:30625-34 PMCID:PMC4215241

[119] Mocellin S,Nitti D.Nitric oxide, a double edged sword in cancer biology: searching for therapeutic opportunities..Med Res Rev2007;27:317-52

[120] Lemkens P,Meens MJPMT,Schiffers PMH.Dual neural peptidase/endothelin-converting enzyme inhibition improves endothelial function in mesenteric resistance arteries of young spontaneously hypertensive rats..J Hypertens2012;30:1799-808

[121] Barhoumi T,Kasal DA,Idris-Khodja N.Erythropoietin-induced hypertension and vascular injury in mice overexpressing human endothelin-1: exercise attenuated hypertension, oxidative stress, inflammation and immune response..J Hypertens2014;32:784-94

[122] Uchmanowicz I.Oxidative stress, frailty and cardiovascular diseases: current evidence..Adv Exp Med Biol2020;1216:65-77

[123] McCullough PA,Becker CR,Lameire N.Risk prediction of contrast-induced nephropathy..Am J Cardiol2006;98:27K-36

[124] Liu ZZ,Lu Y,Nikitina T.Iodinated contrast media cause direct tubular cell damage, leading to oxidative stress, low nitric oxide, and impairment of tubuloglomerular feedback..Am J Physiol Renal Physiol2014;306:F864-72 PMCID:PMC4422341

[125] Pisani A,Andreucci M,Ashour M.Role of reactive oxygen species in pathogenesis of radiocontrast-induced nephropathy..Biomed Res Int2013;2013:868321 PMCID:PMC3891610

[126] Briguori C,Focaccio A,Valgimigli M.Renal insufficiency after contrast media administration trial II (REMEDIAL II): renalguard system in high-risk patients for contrast-induced acute kidney injury..Circulation2011;124:1260-9

[127] Goldenberg I.Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies..CMAJ2005;172:1461-71 PMCID:PMC557983

[128] Briguori C,Quintavalle C,Condorelli G.Contrast-induced acute kidney injury: potential new strategies..Curr Opin Nephrol Hypertens2015;24:145-53

[129] Rezaee MA,Imenshahidi M,Sankian M.Protective effect of erythropoietin on myocardial apoptosis in rats exposed to carbon monoxide..Life Sci2016;148:118-24

[130] Gibson KR,Barrett F,Sharma S.Evaluation of the antioxidant properties of N-acetylcysteine in human platelets: Prerequisite for bioconversion to glutathione for antioxidant and antiplatelet activity..J Cardiovasc Pharmacol2009;54:319-26

[131] Andreucci M,Pisani A,Michael A.Acute kidney injury by radiographic contrast media: pathogenesis and prevention..Biomed Res Int2014;2014:362725 PMCID:PMC4150431

[132] Kwasa EA,Armstrong R.The role of inflammation in contrast-induced nephropathy..Br J Radiol2014;87:20130738 PMCID:PMC4453133

[133] Toso A,Maioli M,Di Vincenzo E.Relationship between inflammation and benefits of early high-dose rosuvastatin on contrast-induced nephropathy in patients with acute coronary syndrome: the pathophysiological link in the PRATO-ACS study..JACC Cardiovasc Interv2014;7:1421-9

[134] Kaya A,Topçu S,Kurt M.Neutrophil-to-lymphocyte ratio predicts contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention..Angiology2014;65:51-6

[135] El Sayed AA,El Nahas AM,Morcos SK.Haemodynamic effects of water-soluble contrast media on the isolated perfused rat kidney..Br J Radiol1991;64:435-9

[136] Limbruno U.Vasomotor effects of iodinated contrast media: just side effects?.Curr Vasc Pharmacol2003;1:321-8

[137] Aggarwal KP,Kakkar M.Nephrolithiasis: molecular mechanism of renal stone formation and the critical role played by modulators..Biomed Res Int2013;2013:292953 PMCID:PMC3787572

[138] Okoye O,Unuigbe E.Frequency and risk factors of contrast-induced nephropathy after contrast procedures in a Nigerian tertiary centre..West Afr J Med2013;32:19-25

[139] Ambrose JA.Inflammation and thrombosis in coronary atherosclerosis: pathophysiologic mechanisms and clinical correlations..Eur Med J2019;4:71-8

[140] Hartman J.Inflammation and atherosclerosis: a review of the role of interleukin-6 in the development of atherosclerosis and the potential for targeted drug therapy..Cardiol Rev2014;22:147-51

[141] Satilmis S.Value of C-reactive protein/albumin ratio in predicting the development of contrast-induced nephropathy in patients with non-ST elevation myocardial infarction..Angiology2020;71:366-71

[142] Buyuklu M,Ozkaraca M,Bakirci EM.Benefical effects of lycopene against contrast medium-induced oxidative stress, inflammation, autophagy, and apoptosis in rat kidney..Hum Exp Toxicol2015;34:487-96

[143] Buyuklu M,Ozkaraca M,Murat Bakirci E.Protective effect of curcumin against contrast induced nephropathy in rat kidney: what is happening to oxidative stress, inflammation, autophagy and apoptosis?.Eur Rev Med Pharmacol Sci2014;18:461-70

[144] Greaves DR.Inflammation and immune responses in atherosclerosis..Trends Immunol2002;23:535-41

[145] Ruparelia N,Fisher EA.Inflammatory processes in cardiovascular disease: a route to targeted therapies..Nat Rev Cardiol2017;14:133-44 PMCID:PMC5525550

[146] Ong SB,Crespo-Avilan GE,Kwek XY.Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities..Pharmacol Ther2018;186:73-87 PMCID:PMC5981007

[147] Rajendran K,Ganesan M.Obesity, inflammation and acute myocardial infarction - expression of leptin, IL-6 and high sensitivity-CRP in Chennai based population..Thromb J2012;10:13 PMCID:PMC3444897

[148] Senguttuvan NB,Agarwal G,Bahl VK.Association of Cytokines IL6, IL10, IL18, TNFα in acute coronary syndrome..J Cardiol Vasc Med2019;5:1-9

[149] Maekawa N,Kanda T,Yamada Y.Improved myocardial ischemia/reperfusion injury in mice lacking tumor necrosis factor-α..J Am Coll Cardiol2002;39:1229-35

[150] Riad A,Sobirey M,Yaulema-Riss A.Toll-like receptor-4 modulates survival by induction of left ventricular remodeling after myocardial infarction in mice..J Immunol2008;180:6954-61

[151] Satoh M,Maesawa C,Ishikawa Y.Activated toll-like receptor 4 in monocytes is associated with heart failure after acute myocardial infarction..Int J Cardiol2006;109:226-34

[152] Shishido T,Yamaguchi S,Nitobe J.Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction..Circulation2003;108:2905-10

[153] Schlitt A,Blankenberg S,Dopheide JF.CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-α levels..Thromb Haemost2004;92:419-24

[154] Mishra J,Tarabishi R,Ma Q.Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery..Lancet2005;365:1231-8

[155] Bachorzewska-Gajewska H,Sitniewska E,Dobrzycki S.Neutrophil-gelatinase-associated lipocalin and renal function after percutaneous coronary interventions..Am J Nephrol2006;26:287-92

[156] Malyszko J,Bachorzewska-Gajewska H,Dobrzycki S.Neutrophil gelatinase-associated lipocalin is a new and sensitive marker of kidney function in chronic kidney disease patients and renal allograft recipients..Transplant Proc2009;41:158-61

[157] Haase M,Haase-Fielitz A,Cruz DN.The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury..J Am Coll Cardiol2011;57:1752-61 PMCID:PMC4866647

[158] Zappitelli M,Arikan AA,Ma Q.Urine neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children: a prospective cohort study..Crit Care2007;11:R84 PMCID:PMC2206519

[159] Nakamura T,Node K,Koide H.Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy..Am J Kidney Dis2006;47:439-44

[160] Baramova EN,Remacle A,Krell HW.Involvement of PA/plasmin system in the processing of pro-MMP-9 and in the second step of pro-MMP-2 activation..FEBS Lett1997;405:157-62

[161] Stringer KA,McCord JM.Antiinflammatory activity of tissue plasminogen activator in the carrageenan rat footpad model..Free Radic Biol Med1997;22:985-8

[162] Yu LR,Daniels JR,Schnackenberg L.Aptamer-based proteomics identifies mortality-associated serum biomarkers in dialysis-dependent AKI patients..Kidney Int Reports2018;3:1202-13 PMCID:PMC6127416

[163] Roelofs JJTH,Leemans JC,de Boer AM.Tissue-type plasminogen activator modulates inflammatory responses and renal function in ischemia reperfusion injury..J Am Soc Nephrol2006;17:131-40

[164] Hu K,Tanaka S,Mars WM.Tissue-type plasminogen activator acts as a cytokine that triggers intracellular signal transduction and induces matrix metalloproteinase-9 gene expression..J Biol Chem2006;281:2120-7

[165] Lin L,Hu K.Tissue plasminogen activator activates NF-κB through a pathway involving annexin A2/CD11b and integrin-linked kinase..J Am Soc Nephrol2012;23:1329-38 PMCID:PMC3402285

[166] Lin L,Mars WM,Hu K.Myeloid-derived tissue-type plasminogen activator promotes macrophage motility through FAK, Rac1, and NF-κB pathways..Am J Pathol2014;184:2757-67 PMCID:PMC4715214

[167] Ferguson-Smith AC,Newman MS,Sehgal PB.Regional localization of the interferon- β2 B-cell stimulatory factor 2/hepatocyte stimulating factor gene to human chromosome 7p15-p21..Genomics1988;2:203-8

[168] Ling W,Ben H,Jianping L.Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography..Nephron - Clin Pract2008;108:c176-81

[169] Nechemia-Arbely Y,Pizov G,Rose-John S.IL-6/IL-6R axis plays a critical role in acute kidney injury..J Am Soc Nephrol2008;19:1106-15 PMCID:PMC2396933

[170] Chen J,John R,Zhou XJ.Early interleukin 6 production by leukocytes during ischemic acute kidney injury is regulated by TLR4..Kidney Int2011;80:504-15 PMCID:PMC3394593

[171] Alladina JW,Hibbert KA,Harris RS.Plasma concentrations of soluble suppression of tumorigenicity-2 and interleukin-6 are predictive of successful liberation from mechanical ventilation in patients with the acute respiratory distress syndrome..Crit Care Med2016;44:1735-43 PMCID:PMC4988326

[172] Nogare AL,Veronese FJ,Manfro RC.Noninvasive analyses of kidney injury molecule-1 messenger RNA in kidney transplant recipients with graft dysfunction..Transplant Proc2012;44:2297-9

[173] Slocum JL,Pennathur S.Marking renal injury: can we move beyond serum creatinine?.Transl Res2012;159:277-89 PMCID:PMC3308350

[174] Soto K,Rodrigues B,Frade F.Cystatin C as a marker of acute kidney injury in the emergency department..Clin J Am Soc Nephrol2010;5:1745-54 PMCID:PMC2974372

[175] Marenzi G.Can contrast-induced nephropathy after percutaneous coronary intervention be accurately predicted with a risk score?.Nat Clin Pract Cardiovasc Med2005;2:80-1

[176] Tublin ME,Tessler FN.Current concepts in contrast media-induced nephropathy..Am J Roentgenol1998;171:933-9